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Abstract: 
Iron (Fe) is an essential trace metal involved in numerous cellular processes. Iron deficiency (ID) is reported as 
the most prevalent nutritional problem worldwide. Increasing evidence suggests that ID is associated with 
altered neurotransmitter metabolism and a risk factor for manganese (Mn) neurotoxicity. Though recent studies 
have established differences in which the female brain responds to ID-related neurochemical alterations versus 
the male brain, little is known about the interactions of dietary ID, Mn exposure, and sex on γ-amino butyric 
acid (GABA). Male and female Sprague-Dawley rats were randomly divided into four dietary treatment groups: 
control (CN), control/ Mn supplemented, ID, and ID/Mn supplemented. After 6 weeks of treatment, both ID 
diets caused a highly significant decrease in Fe concentrations across all brain regions compared to CN in both 
sexes. Both ID and Mn supplementation led to significant accumulation of Mn across all brain regions in both 
sexes. There was no main effect of sex on Fe or Mn accumulation. Striatal synaptosomes were utilized to 
examine the effect of dietary intervention on 
3
H-GABA uptake. At 4 weeks, there was a significant correlation 
between Fe concentration and 
3
H-GABA uptake in male rats (p < 0.05). At 6 weeks, there was a significant 
inverse correlation between Mn concentration and 
3
H-GABA uptake in male and female rats and a positive 
correlation between Fe concentration and 
3
H-GABA uptake in female rats (p < 0.05). In conclusion, ID-
associated Mn accumulation is similar in both sexes, with Mn levels affecting GABA uptake in both sexes in a 
comparable fashion. 
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Article: 
Iron (Fe) is an essential trace metal involved in numerous and important processes in the body. Fe plays a 
crucial role in several cellular processes and as a component of various enzymes (Beard et al., 1993). Among 
the myriad of biological functions of Fe is the role it plays in the function and maintenance of the central 
nervous system, including neurotransmitter synthesis and metabolism, myelination, and energy metabolism 
(Beard et al., 1993, 2002). Iron deficiency (ID) is reported as the most prevalent nutritional problem in the 
world, affecting an estimated 600–700 million individuals worldwide (FAO/WHO, 1998). ID is associated with 
malformation of red blood cells, growth impairment, perturbations in thermoregulation, and deficits in cognitive 
function (see Beard et al., 1993). 
 
The neurobiological sequelae of ID in humans include variations in behavior, cognition, and neurotransmitter 
metabolism (Beard, 2001). Over two decades ago, ID was linked to decreased dopamine D2 receptors in 
striatum (Ashkenazi et al., 1982; Youdim et al., 1989), and presently it is well recognized that ID leads to 
increased extracellular dopamine (Beard et al., 1994; Chen et al., 1995; Nelson et al., 1997) and decreased 
dopamine transporter (DAT) and dopamine receptor functioning (Erikson et al., 2000, 2001). Knowing some of 
the behavioral alterations associated with ID, increasing evidence suggests that ID is associated with 
perturbations in additional neurotransmitter levels (e.g., γ-amino butyric acid [GABA], glutamate, and 
serotonin) (Burhans et al., 2005; Garcia et al., 2006; Li, 1998). 
 
Recently, it has become clear that ID is a risk factor for manganese (Mn) accumulation (Davis et al., 1992; 
Erikson et al., 2002; Finley, 1999; Kwik-Uribe et al., 1999). High levels of Mn in the globus pallidus, caudate 
putamen, and subthalamic nuclei may contribute to the susceptibility of the striatum to Mn toxicity (Montes et 
al., 2000; Verity, 1999). Transport of both Mn and Fe to extrahepatic tissues, including the brain, relies upon 
transferrin-mediated endocytosis (Crowe and Morgan, 1992; Malecki et al., 1999). Recently, divalent metal 
trans-porter (DMT-1) has been identified as an important protein in the proper cellular transport of Fe and Mn 
(Conrad et al., 2000; Roth and Garrick, 2003). To date, no study has looked at sex differences in this scenario. 
 
Previous studies examining the sex differences on ID-related neurochemical alterations have targeted dopamine 
biology and established that there are clear differences in the manner that the female brain responds to ID 
compared to the male brain (Erikson et al., 2000, 2001). Specifically, ID male rats exhibited decreased DAT 
density in caudate putamen and nucleus accumbens, whereas female ID rats had decreased DAT density  
in nucleus accumbens only, compared to controls (CNs) (Erikson et al., 2000). Early ID in male mice had a 
greater impact on decreasing DAT density in caudate putamen compared to that in female mice (Morse et al., 
1999). To date, very little is known about the interactions of dietary ID, exposure to Mn, and sex of the subject 
on GABA. 
 
GABA is the most abundant inhibitory neurotransmitter in the adult brain (Beleboni et al., 2004; Olsen and 
DeLorey, 1999). Glutamate is converted to GABA by decarboxylation via glutamate decarboxylase (GAD) and 
is degraded via GABA transaminase. Cortical glutamate afferents project into the striatum where, in concert 
with GABA and dopamine, motor behaviors are controlled (Carlsson M. and Carlsson A., 1990). Altered 
GABA metabolism due to ID has been shown (Li, 1998), but absolute changes in GABA concentration were 
not detected. Further, Li’s study demonstrated increased glutamate concentration due to ID, potentially caused 
by decreased GAD activity. Reports of GABA concentrations in the rat brain upon Mn exposure are 
inconsistent. For example, exposure to 6 mg Mn/kg/day led to a significant increase in brain Mn concentrations 
and significant decrease in GABA concentrations (Chandra et al., 1982). Another report showed that rats 
exposed  to 20 mg Mn/kg/day had significantly increased brain Mn and GABA concentrations (Lipe et al., 
1999). Gwiazda et al. (2002) found a significant 16% increase in striatal GABA concentrations resulting from 
cumulative low-dose Mn exposure in a pre-Parkinsonian rat model. Consequently, it appears that a relationship 
exists between the severity of Mn exposure and GABA concentrations, with lower Mn exposure leading to 
decreased GABA, and high Mn exposure leading to increased GABA concentrations. More recently, it has been 
shown that ID-associated Mn accumulation in the male striatum is negatively correlated with GABA 
concentrations (Erikson et al., 2002), but there are no data on the female striatum. 
 
The goals of this study were to examine sex differences in (1) Mn accumulation due to environmental exposure 
(via the drinking water), (2) ID-associated Mn accumulation, and (3) the effect of the Mn accumulation on 
3
H-
GABA uptake. 
 
MATERIALS AND METHODS 
Animals. Male and female 21-day-old Sprague-Dawley rats (Harlan Sprague-Dawley, Indianapolis, IN) were 
randomly divided into four dietary treatment groups as in previous studies (Anderson et al., 2006; Erikson et al., 
2002): CN (35 mg Fe/kg, 10 mg Mn/kg diet and drinking water), control Mn supplemented (CNMn; control diet 
and 1 g Mn [as MnCl2]/l drinking water), iron deficient (ID; 4 mg Fe/kg, 10 mg Mn/kg diet and drinking water), 
and iron deficient/Mn supplemented (IDMn; 4 mg Fe/kg, 10 mg Mn/kg diet and 1 g Mn/l drinking water). Diets 
were obtained from Bio-Serv, (Frenchtown, NJ) and certified for metal content. Rats had free access to food and 
water 24 h/day, and the lights were turned off between 1800 and 600 h. Room temperature was maintained at 25 
± 1 °C. After 6 weeks of dietary treatment, the rats were sacrificed and brains removed for metal (n = 48) and 
synaptosomal (n = 48 in each of the three individual experiments) analyses. The University of North Carolina at 
Greensboro Animal Care and Use Committee approved all the animal procedures. 
 
Hematological measurements. Hematocrit was measured weekly via blood samples acquired by tail prick, and 
determined by centrifugation of blood collected into heparinized microcapillary tubes. Blood samples were 
collected at the end of the experiment into heparinized tubes; aliquots were used for hematocrit and the 
remaining blood was cooled to 4 °C and centrifuged in a clinical centrifuge for 15 min to separate cells from 
plasma. Plasma was frozen at -80 °C until analyzed for Mn. Plasma Mn was measured utilizing graphite furnace 
atomic absorption spectroscopy (Varian AA240, Varian, Inc. Palo Alto, CA). 
 
Brain Fe and Mn. Brains were dissected into four regions: caudate putamen, globus pallidus, substantia nigra, 
and cerebellum. Regions were selected based on their varied concentrations of Fe and Mn and the known 
differential responses to alterations in dietary Fe and Mn levels (Anderson et al., 2006; Erikson et al., 2002). 
Tissue Mn and Fe concentrations were measured with graphite furnace atomic absorption spectroscopy (Varian 
AA240, Varian, Inc). Brain regions were digested in ultrapure nitric acid (1:10 wt/vol dilution) for 48–72 h in a 
sandbath (60 °C). An aliquot of 100 μl of digested tissue was brought to 1 ml total volume with 2% nitric acid 
and analyzed for Mn and Fe. 
 
In vitro studies. We used striatal synaptosomes to indirectly assess the effect of ID and Mn supplementation on 
disturbances in GABA biology by measuring 
3
H-GABA uptake. We followed a modified method of Cotman et 
al. (1981) (Erikson et al., 2000, 2001). Briefly, striata from two rats per treatment group of each sex were 
pooled for each individual experiment. The tissue was homogenized using a Teflon/glass homogenizer in 20 
volumes of ice-cold 0.32M sucrose-HEPES, pH 7.4. The homogenate was then centrifuged at 2000 X g for 10 
min at 4 °C. The supernatant was removed and centrifuged at 20,000 X g for 15 min at 4 °C. The pellet was 
resuspended in 10 ml fresh ice-cold Krebs-Ringer-HEPES (KRH) buffer (118.4mM NaCl, 1.18mM 
MgSO4,4.7mM KCl, 1.2mM KH2PO4, 10.0mM HEPES, 5.6mM dextrose [pH 7.4]). An aliquot of 200 μl of the 
synaptosomes was placed in a tube with 50 μl KRH buffer. A 10-μl aliquot of 
3
H-GABA (50nM at a specific 
activity of 94 Ci/mmol) (NEN, Boston, MA) was added to each tube, and tubes were incubated for 15 min at 37 
°C. The reaction was stopped by adding 5 ml ice-cold KRH buffer to each tube followed by rapid filtration 
through a GF/F Whatman fiberglass filter on a Millipore sampling manifold. Filters were washed twice with 
ice-cold KRH, placed in scintillation vials with 5 ml scintillation cocktail, and counted on a Beckman LS 
scintillation counter (Beckman, Fullerton, CA). An additional set of tubes, one for each treatment group, was 
incubated on ice (approximately 4 °C) to determine nonspecific uptake. Protein analysis was performed 
utilizing the bicinchoninic acid method (Pierce, Rockford, IL). 
 
To assess Mn and Fe concentration in the striatal synaptosomes, the un-used fraction of synaptosomes from 
each dietary treatment was centrifuged at 2000 X g for 10 min at 4 °C. The supernatant was removed and the 
pellet was digested in 500 μl ultrapure nitric acid for 48 h. Mn and Fe concentration was deter-mined by 
graphite furnace atomic absorption spectroscopy as described above. 
 
Statistical analysis. The data were analyzed with the SPSS system v11.5 statistical analysis package. Data were 
examined for normality of distribution using a one-sample Kolmogorov-Smirnov test and presence of outliers 
by boxplot analysis. One-way ANOVA was used to test for effects of dietary treatment on clinical parameters. 
Repeated-measures ANOVA with repeated-measures factors (brain regions) and between-groups factors (sex 
and dietary treatment) was used to test for interactions between sex, dietary treatments, and brain regions for 
amino acid and metals data. For hematological measures, two-way ANOVA was performed with sex and diet as 
the main effects. Tukey’s post hoc analysis was performed when the p value for the respective parameter was 
statistically significant (p < 0.05). Correlational analysis was performed to ex-amine the relationships between 
(1) Fe levels and Mn levels within brain regions, (2) Fe levels and 
3
H-GABA uptake within synaptosomes, and 
(3) Mn supplementation and 
3
H-GABA uptake within synaptosomes. Dunnett’s procedure was used to evaluate 
mean differences from CN. The alpha level for the analyses was p < 0.05. 
 
RESULTS 
Body Weights, Tissue Weights and Hematology 
Both ID diets (ID and IDMn) caused significant decreases in body weight (Table 1). Hematocrit was 
significantly lower in the ID and IDMn groups indicating severe anemia (Table 1). A significant difference (p < 
0.05) was observed in plasma Mn in male rats, with those rats receiving the ID diet having higher Mn levels 
than CNs (Table 1). Plasma Mn was not significantly different between the dietary treatments in female rats 
(Table 1). Mn supplementation did not affect body weight, hematocrit, or plasma Mn in the rats receiving the 
control diet. 
 
 
Brain Regional Fe and Mn Concentrations 
Both iron-deficient diets (ID and IDMn) caused a significant decrease (p < 0.001) in Fe concentrations across 
all brain regions compared to CNs in both females (Fig. 1A) and males (Fig. 1B). Mn supplementation also 
significantly lowered Fe concentrations across most brain regions (p = 0.001) in both sexes. There were no 
significant interactions between dietary Fe, Mn, and sex across brain regions. Univariate analysis within brain 
regions revealed that there were significant differences in Fe levels in rats fed the experimental diets com-pared 
to CN rats (p < 0.05) (Figs. 1A and 1B). 
 
3
H-GABA Uptake 
After 4 weeks of dietary treatment, there was a significant positive correlation between synaptosomal Fe 
concentration and 
3
H-GABA uptake in male rats (R = 0.342; p < 0.05) (Fig. 3B). A similar relationship was not 
seen in female rats (Fig. 3D). There was no significant correlation between synaptosomal Mn concentration and 
3
H-GABA uptake in those synaptosomes isolated from either male (Fig. 3A) or female (Fig. 3C) rats at 4 
weeks. At 6 weeks of dietary intervention, there was a significant inverse correlation between synaptosomal Mn 
concentration and 3 H-GABA uptake in male rats (R = -0.356; p < 0.05) (Fig. 4A) and female rats (R = -0.380; 
p < 0.05) (Fig. 4C). Specifically, uptake of 
3
H-GABA was significantly (p < 0.05) decreased in CNMn, ID, and 
IDMn in males (Fig. 4A inset) and in CNMn in female rats at 6 weeks (Fig. 4C inset). Additionally, there was a 
significant positive correlation between synaptosomal Fe concentration and 3H-GABA uptake in female rats at 
6 weeks (R = 0.502; p < 0.01) (Fig. 4D). There was no significant correlation between Fe concentration and 3H-
GABA uptake in male rats at 6 weeks (Fig. 4B). 
 
DISCUSSION 
Several novel findings emerged from the current study. First, our dietary protocol achieved elevated systemic 
Mn levels which were related to both dietary ID and Mn supplementation (Table 1). Second, Fe and Mn 
accumulated in a heterogeneous fashion similarly in both female (Figs. 1A and 2A) and male (Figs. 1B and 2B) 
rats, with animals receiving the ID diet having lower Fe concentrations and Mn-supplemented animals having 
higher Mn concentrations than CN animals. There was significant accumulation of Mn in the striatum as a 
result of ID (Figs. 2A and 2B). Third, using striatal synaptosomes, a significant positive correlation was seen 
between synaptosomal Fe concentration and 3H-GABA uptake in male rats only at 4 weeks of dietary 
intervention (Fig. 3B). At 6 weeks of dietary intervention, a significant negative correlation was seen between 
synaptosomal Mn concentration and 
3
H-GABA uptake in both male and female rats (Figs. 4A and 4B). 
Additionally, a significant positive correlation between synaptosomal Fe concentration and 3H-GABA uptake 
was observed in female rats at 6 weeks (Fig. 4D). 
 
As in previous studies (Erikson et al., 2000, 2001, 2002), Fe accumulated in a heterogeneous fashion in the 
brain with those rats receiving the ID and IDMn diet accumulating significantly less Fe than CN rats in both 
females (Fig. 1A) and males (Fig. 1B) in most brain regions. Additionally, Mn supplementation significantly 
attenuated Fe accumulation in the striatum (Figs. 1A and 1B). Our data corroborate a previous study in which 
there was no statistical difference observed in brain regional Fe concentrations between male and female rats 
receiving an ID diet (Erikson et al., 2000). 
 
The effect of ID-associated Mn accumulation in the female rat brain had yet to be examined. While ID is not a 
public health issue to the extent that it is in developing countries, the percentage of toddlers, adolescents, and 
particularly childbearing aged women (vulnerable subpopulations) affected by ID remain higher than the 
Healthy People 2010 Objectives set forth (Looker et al., 1997). Hence, it is imperative to include females in 
these studies that focus on ID-associated neurotoxicity. 
 
 
To our knowledge, this is the first study to examine this scenario. Mn accumulated in a heterogeneous fashion 
in the brain with supplemented animals accumulating significantly more Mn than CN animals in most brain 
regions (Figs. 2A and 2B). There was no main effect of sex on Mn accumulation, and the ID-associated Mn 
accumulation pattern was similar in the caudate putamen and globus pallidus. Specifically, the male and female 
IDMn rats dramatically accumulated Mn in these two regions compared to CN rats. In a previous study, the 
effect of the dietary intervention on Mn accumulation in the male rat brain was examined and a similar 
accumulation was observed (Erikson et al., 2002). Although no statistically significant difference in Mn 
accumulation was observed between male and female rats, both genders had ID-associated Mn accumulation. 
How these changes in metal concentrations affect GABA uptake was our next question since decreased striatal 
GABA content (Erikson et al., 2002; Gwiazda et al., 2002) suggests altered reuptake GABA due to Mn 
exposure. 
 
Previous studies suggest that decreased tissue levels of a neurotransmitter are due to decreased uptake of that 
neurochemical (reviewed in Gainetdinov et al., 1998). Knowing that Mn accumulation leads to decreased 
GABA levels in the striatum, we hypothesized that this effect is due to impaired uptake. Therefore, we set out 
to examine this relationship directly by measuring 3H-GABA uptake in striatal synaptosomes. Synaptosomes 
were chosen due to their relative simplicity and their proven sensitivity to manipulation of neurotransmitter 
uptake. Dissociation from other interacting neuronal systems is advantageous in this case in order to provide 
direct interpretation of results. ID was associated with decreased 3H-GABA uptake in male rats at 4 weeks (Fig. 
3B). No significant correlation between Mn concentration and 3H-GABA uptake was seen in either sex at 4 
weeks (Figs. 3A and 3C). This finding was not surprising for we recently reported that 4 weeks of dietary 
treatment did not cause a significant accumulation of striatal Mn (Anderson et al., 2006). However, as reported 
here and previously (Erikson et al., 2002), 6 weeks of dietary treatment causes a significant accumulation of 
striatal Mn due to both ID and Mn supplementation (Figs. 2A and 2B). Thus, as expected Mn accumulation was 
associated with decreased 3H-GABA uptake in both male and female rats after 6 weeks of dietary treatment 
(Figs. 4A and 4C).  
 
 
Additionally, ID was associated with decreased 
3
H-GABA up-take in female rats at 6 weeks (R = 0.502) (p < 
0.01) (Fig. 4D). To our knowledge, this is the first report of impaired 3H-GABA uptake in striatal synaptosomes 
derived from female rats fed an ID diet. Furthermore, the discovery that the male rats were impacted by ID in 
an opposite manner compared to females (i.e., 4 weeks of ID led to decreased uptake but 6 weeks had no effect) 
clearly shows a sex difference in terms of the effect of ID on 3H-GABA uptake. In this study, both male and 
female rats accumulated Mn due to IDMn treatment and this effect is likely causing the significant decrease in 
3
H-GABA uptake ob-\served at 6 weeks in both sexes (Figs. 4A and 4C). 
 
Decreased 
3
H-GABA uptake could be a result of altered GABA transporter number and function. ID has been 
shown to affect DAT number and function (Erikson et al., 2000), and there may be a similar effect of ID on the 
GABA transporter. GABA transporter is a member of the SLC-6 transporter family that also contains DAT 
(Gether et al., 2006) and may have similar vulnerabilities to ID. In the current study, this question was probed 
pharmacologically with nipecotic acid, a GABA transporter inhibitor (data not shown). Treatment with the 
ED50 of nipecotic acid inhibited uptake of 3H-GABA by at least 50% in all four treatment groups across both 
genders, indicating no change in drug efficacy or in transporter functioning. In other words, the treatment 
groups had decreased 
3
H-GABA uptake compared to the CN group in both sexes before the addition of 
nipecotic acid to the synaptosomes, yet they responded to the drug in the same manner as CN, indirectly 
indicating decreased density of the GABA transporter. However, as this pharmacological approach is an indirect 
method of analyzing the functioning of the GABA transporter, future studies in our laboratory will explore this 
more directly using protein analysis (e.g., immunoblot) to assess density and radioligand-binding assays to 
assess functionality. 
 
A decrease in GABA uptake would indicate increased extracellular GABA, which in vivo would lead to 
increased inhibitory activity leading to increased hypokinetic activity, a hallmark of Mn neurotoxicity. A study 
of Mn-exposed young adult rats observed a decrease in locomotor activity (Normandin et al., 2004). Motor 
deficits were also observed in a study utilizing a pre-Parkinsonian rat model and cumulative low-dose Mn 
exposure (Gwiazda et al., 2002). Furthermore, these changes did not alter dopamine, suggesting that changes in 
GABA precede changes in dopamine. Dystonia, a characteristic of Mn neurotoxicity (Cersosimo and Koller, 
2006; Normandin et al., 2004), is associated with dysfunction of the globus pallidus (Calne et al., 1994), a 
GABAergic region of the brain and target of Mn accumulation during toxic exposure (Erikson et al., 2002; 
Fitsanakis and Aschner, 2005; Garcia et al., 2006). 
 
In conclusion, ID affected 
3
H-GABA uptake in male rats after 4 weeks of exposure and females after 6 weeks, 
demonstrating sex difference in the response to dietary ID in terms of a neurochemical outcome. ID-associated 
Mn accumulation was similar in the brains of both male and female rats, as was an inverse relationship between 
Mn and 
3
H-GABA uptake observed in both sexes at 6 weeks supporting previous data illustrating disturbances 
in GABA levels as a result of Mn exposure. It is possible that alterations in dopamine metabolism observed in 
ID (Erikson et al., 2000, 2001) may be due to abnormal GABAergic firing as a result of Mn accumulation, 
supporting the hypothesis that disturbances in GABA may precede perturbations in dopamine metabolism as 
Mn accumulation is targeted to the globus pallidus (Figs. 2A and 2B) (Erikson et al., 2002), a GABA-rich brain 
region. Based on our findings in this study, we hypothesize that extracellular GABA (related to 
neurotransmission) levels are increased due to Mn accumulation compared to CN rats. Currently, there exists a 
lack of data evaluating the effect of ID and Mn on extracellular GABA concentrations in vivo which would 
reflect synaptic levels of GABA that modulate neurotransmission. Continuing studies in our laboratory will 
pharmacologically probe the effect of ID and Mn exposure on these extracellular GABA levels in order to fully 
understand the neurobiological consequences of Mn toxicity especially related to dietary ID.  
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